Aspergillus is a genus of filamentous fungi that encompasses a diverse group of molds commonly found in the environment. With over 200 known species, Aspergillus plays a significant role in decomposing organic matter and contributing to nutrient cycling. However, some species within this genus can pose health risks, particularly for immunocompromised individuals. Aspergillus fumigatus is the most clinically relevant species, causing a range of respiratory infections, including allergic bronchopulmonary aspergillosis (ABPA), invasive aspergillosis, and chronic pulmonary aspergillosis. Infections by Aspergillus species are often associated with individuals with weakened immune systems, such as those undergoing chemotherapy or organ transplantation. Inhalation of Aspergillus spores can lead to colonization of the respiratory tract, with invasive disease occurring in severe cases. Allergic reactions to Aspergillus antigens can also result in hypersensitivity lung diseases. Diagnosing Aspergillus infections requires a combination of clinical evaluation, imaging studies, and laboratory tests, including cultures and molecular techniques. Antifungal medications, such as voriconazole, are commonly used for treatment.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation